These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22580227)

  • 1. Modular theranostic prodrug based on a FRET-activated self-immolative linker.
    Redy O; Shabat D
    J Control Release; 2012 Dec; 164(3):276-82. PubMed ID: 22580227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.
    Redy-Keisar O; Ferber S; Satchi-Fainaro R; Shabat D
    ChemMedChem; 2015 Jun; 10(6):999-1007. PubMed ID: 25847527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier.
    Sagi A; Segal E; Satchi-Fainaro R; Shabat D
    Bioorg Med Chem; 2007 Jun; 15(11):3720-7. PubMed ID: 17416532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry.
    Gopin A; Ebner S; Attali B; Shabat D
    Bioconjug Chem; 2006; 17(6):1432-40. PubMed ID: 17105221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
    Hu Y; Zeng F
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging of doxorubicin release from theranostic macromolecular prodrugs via fluorescence resonance energy transfer.
    Krüger HR; Schütz I; Justies A; Licha K; Welker P; Haucke V; Calderón M
    J Control Release; 2014 Nov; 194():189-96. PubMed ID: 25176577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of self-immolative linkers for tumour-activated prodrug therapy.
    Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
    Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple FRET-based modular design for diagnostic probes.
    Redy O; Kisin-Finfer E; Sella E; Shabat D
    Org Biomol Chem; 2012 Jan; 10(4):710-5. PubMed ID: 22159494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells.
    Bhuniya S; Lee MH; Jeon HM; Han JH; Lee JH; Park N; Maiti S; Kang C; Kim JS
    Chem Commun (Camb); 2013 Aug; 49(64):7141-3. PubMed ID: 23831834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
    Conover CD; Greenwald RB; Pendri A; Shum KL
    Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel polymeric prodrug with multivalent components for cancer therapy.
    Khandare JJ; Chandna P; Wang Y; Pozharov VP; Minko T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):929-37. PubMed ID: 16469865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing SN38 prodrug delivery using a self-immolative linker and endogenous albumin transport.
    Jiang X; Zhu L; Wei Q; Lu W; Yu J; Zhu S
    J Control Release; 2024 May; 369():622-629. PubMed ID: 38604383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug.
    Xu Z; Zheng W; Yin Z
    Arch Pharm (Weinheim); 2014 Apr; 347(4):240-6. PubMed ID: 24402828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
    Bala V; Rao S; Boyd BJ; Prestidge CA
    J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyprodrug amphiphiles: hierarchical assemblies for shape-regulated cellular internalization, trafficking, and drug delivery.
    Hu X; Hu J; Tian J; Ge Z; Zhang G; Luo K; Liu S
    J Am Chem Soc; 2013 Nov; 135(46):17617-29. PubMed ID: 24160840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier.
    Tang Q; Cao B; Cheng G
    Chem Commun (Camb); 2014 Feb; 50(11):1323-5. PubMed ID: 24343195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light-triggered, self-immolative nucleic Acid-drug nanostructures.
    Tan X; Li BB; Lu X; Jia F; Santori C; Menon P; Li H; Zhang B; Zhao JJ; Zhang K
    J Am Chem Soc; 2015 May; 137(19):6112-5. PubMed ID: 25924099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.